LSE - Delayed Quote CHF

Tecan Group AG (0QLN.L)

175.00
-0.89
(-0.51%)
As of 8:49:00 AM GMT+1. Market Open.
Loading Chart for 0QLN.L
  • Previous Close 175.89
  • Open 174.00
  • Bid --
  • Ask --
  • Day's Range 173.70 - 175.00
  • 52 Week Range 173.70 - 412.60
  • Volume 126
  • Avg. Volume 7,876
  • Market Cap (intraday) 2.063B
  • Beta (5Y Monthly) 0.97
  • PE Ratio (TTM) 0.18
  • EPS (TTM) 9.88
  • Earnings Date Aug 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

www.tecan.com

3,074

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0QLN.L

View More

Performance Overview: 0QLN.L

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

0QLN.L
11.23%
MSCI WORLD (^990100-USD-STRD)
4.41%

1-Year Return

0QLN.L
0.00%
MSCI WORLD (^990100-USD-STRD)
11.25%

3-Year Return

0QLN.L
39.90%
MSCI WORLD (^990100-USD-STRD)
45.76%

5-Year Return

0QLN.L
45.42%
MSCI WORLD (^990100-USD-STRD)
86.65%

Compare To: 0QLN.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0QLN.L

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.24%

  • Return on Assets (ttm)

    2.08%

  • Return on Equity (ttm)

    4.86%

  • Revenue (ttm)

    934.28M

  • Net Income Avi to Common (ttm)

    67.66M

  • Diluted EPS (ttm)

    9.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    406.01M

  • Total Debt/Equity (mrq)

    22.39%

  • Levered Free Cash Flow (ttm)

    101.22M

Research Analysis: 0QLN.L

View More

Company Insights: 0QLN.L

Research Reports: 0QLN.L

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.